glp-1 agonist weight loss Rx Trends: Real-World Data on GLP-1s for GLP-1 Medications: Everything You Need

These individual unimolecular multi-agonists activities seemed to harmonize the overall metabolic efficacy, which predominantly results from synergistic glucagon action to increase energy expenditure, GLP-1 action to reduce caloric intake and improve glucose control, and GIP action to potentiate the incretin effect and buffer against the diabetogenic effect of inherent glucagon activity

Aging Cell

[DOI] [PubMed] [Google Scholar] 647.Kumarathurai P., Anholm C., Larsen B.S., Olsen R.H., Madsbad S., Kristiansen O

DPP-IV-Resistant, Long-Acting Oxyntomodulin Derivatives

Future research into once-weekly insulins could reduce this number even further